These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2669684)

  • 1. Morphogenesis and morphology of HIV. Structure-function relations.
    Gelderblom HR; Ozel M; Pauli G
    Arch Virol; 1989; 106(1-2):1-13. PubMed ID: 2669684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LAV/HTLV-III: fine-structure analysis, localization of structural proteins, and detection of envelope antigens by patient sera.
    Pauli G; Hausmann E; Weiss R; Clapham P; Schneider J; Hunsmann G; Gallo RC; Daniel MD; Koch MA; Gelderblom H
    Haematol Blood Transfus; 1987; 31():407-9. PubMed ID: 3481756
    [No Abstract]   [Full Text] [Related]  

  • 3. The organization of the envelope projections on the surface of HIV.
    Ozel M; Pauli G; Gelderblom HR
    Arch Virol; 1988; 100(3-4):255-66. PubMed ID: 3401118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural biology of HIV.
    Turner BG; Summers MF
    J Mol Biol; 1999 Jan; 285(1):1-32. PubMed ID: 9878383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins.
    Gelderblom HR; Hausmann EH; Ozel M; Pauli G; Koch MA
    Virology; 1987 Jan; 156(1):171-6. PubMed ID: 3643678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients.
    Broliden PA; Morfeldt-Månsson L; Rosen J; Jondal M; Wahren B
    Clin Exp Immunol; 1989 May; 76(2):216-21. PubMed ID: 2503275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV envelope-CD4 interaction not inhibited by synthetic octapeptides.
    Sodroski J; Kowalski M; Dorfman T; Basiripour L; Rosen C; Haseltine W
    Lancet; 1987 Jun; 1(8547):1428-9. PubMed ID: 2884513
    [No Abstract]   [Full Text] [Related]  

  • 8. Part of AIDS virus is patented.
    Sun M
    Science; 1988 Feb; 239(4843):970. PubMed ID: 2830668
    [No Abstract]   [Full Text] [Related]  

  • 9. Morphogenesis of the Infectious HIV-1 Virion.
    Sakuragi J
    Front Microbiol; 2011; 2():242. PubMed ID: 22163227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harming and protecting responses to HIV.
    Lanzavecchia A
    Res Immunol; 1989 Jan; 140(1):99-103; discussion 123-4. PubMed ID: 2567046
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1.
    Thomas HI; Wilson S; O'Toole CM; Lister CM; Saeed AM; Watkins RP; Morgan-Capner P
    Clin Exp Immunol; 1996 Feb; 103(2):185-91. PubMed ID: 8565298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphometric analysis of envelope glycoprotein gp120 distribution on HIV-1 virions.
    Hart TK; Klinkner AM; Ventre J; Bugelski PJ
    J Histochem Cytochem; 1993 Feb; 41(2):265-71. PubMed ID: 7678271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-specific T lymphocyte immunity in mice immunized with a recombinant vaccinia virus.
    Michel F; Hoffenbach A; Langlade-Demoyen P; Guy B; Girard M; Lecocq JP; Wain-Hobson S; Kieny MP; Plata F
    Eur J Immunol; 1988 Dec; 18(12):1917-24. PubMed ID: 2905993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication of human immunodeficiency virus in HL-60 cells.
    Semmel M; Macho A; Morozov V; Coulaud D; Alileche A; Plaisance S; Aguilar J; Jasmin C
    Res Virol; 1992; 143(4):249-58. PubMed ID: 1384093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of CD4 glycoprotein determinant-HIV envelope protein interactions: perspectives for analog and vaccine development.
    Farrar WL; Harel-Bellan A; Ferris DK
    Crit Rev Immunol; 1988; 8(4):315-39. PubMed ID: 2850890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up of subjects with isolated and persistent anti-core (anti-p24 or anti-p17) antibodies to HIV.
    Lefrère JJ; Couroucé AM; Lucotte G; Boitard C; Kaplan C; Nicolas JC; Bricout F; Lambin P; Doinel C; Muller JY
    AIDS; 1988 Aug; 2(4):287-90. PubMed ID: 2902864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and antigenic characterization of the proteins of human T-cell leukemia viruses and their relationships to the gene products of other retroviruses.
    Oroszlan S; Copeland TD; Rice NR; Smythers GW; Tsai WP; Yoshinaka Y; Shimotohno K
    Princess Takamatsu Symp; 1984; 15():147-57. PubMed ID: 6100635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructural evidence of an interaction between Env and Gag proteins during assembly of HIV type 1.
    Bugelski PJ; Maleeff BE; Klinkner AM; Ventre J; Hart TK
    AIDS Res Hum Retroviruses; 1995 Jan; 11(1):55-64. PubMed ID: 7734197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer emulation of thin section electron microscopy predicts an envelope-associated icosadeltahedral capsid for human immunodeficiency virus.
    Marx PA; Munn RJ; Joy KI
    Lab Invest; 1988 Jan; 58(1):112-8. PubMed ID: 3336203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.
    Binley JM; Sanders RW; Clas B; Schuelke N; Master A; Guo Y; Kajumo F; Anselma DJ; Maddon PJ; Olson WC; Moore JP
    J Virol; 2000 Jan; 74(2):627-43. PubMed ID: 10623724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.